Dilikoglu ResearchIDEAS. ANALYSIS. PERSPECTIVE.
AI COMPUTE · AMD

Advanced Micro Devices stock research & valuation

Published Coverage · Fabless semiconductor designer · accelerators / processors

Overview

DILIKOGLU RESEARCH VIEW · MODEL 2026-10-07

Investment summary

BUY · High risk · Target $610 USD · 12–18 months · Report 2026-10-18
Reference $528.75 (2026-10-16); implied upside 15.4%. Dated reference, not a current quote. Read recommendation →

Frozen publication snapshot: Base intrinsic value $607.56 rounded to the nearest $5. The $610 target implies 15.4% upside; unrounded Base upside is 14.9%. Probability-weighted value is $591.16; simulation median $484.44 is below the reference. BUY is a high-risk, Base-led judgment.

Rounded Base target above +15% implies BUY, below -15% SELL, otherwise HOLD against the dated reference over 12–18 months. Rounding is material here: unrounded Base upside is 14.9%, versus 15.4% for the $610 target. High risk; simulation frequencies are not calibrated probabilities.

AMD’s opportunity combines Instinct accelerator adoption with EPYC and client processor growth. The model tests management’s growth ambitions against operating investment, cash conversion and customer-warrant dilution.

Current model Base fair value / share
$607.56
Current model probability-weighted fair value / share
$591.16
Key catalyst
MI450 / Helios delivery, EPYC adoption and Q3 guidance execution
Principal risk
Helios qualification and customer deployment may lag expectations.

USD per share. Valuations are DR model estimates, separate from dated report targets. Scenario probabilities and supporting assumptions appear below.

Latest available price
Unavailable
Base return vs latest price
—

Evidence review →

Primary operating KPI
Instinct ramp, EPYC growth, operating leverage and cash conversion
Last recorded model update
2026-10-07
Explore the analytical model → · Portfolio Analytics →

Investment Thesis

AI platform share gains versus execution, investment and warrant dilution

  1. Instinct and EPYC estimates reconcile to reported Data Center revenue.
  2. Operating leverage is anchored to quarterly guidance and long-term targets, with SBC retained as an economic cost.
  3. Cash commitments and conditional warrants determine the value captured by existing shareholders.

Variant perception

Strong AI demand does not remove the need to underwrite product delivery, cash conversion and conditional dilution.

What could make us wrong

Persistent guidance misses, weak operating leverage or customer deployment failure

Key catalysts

MI450 / Helios delivery, EPYC adoption and Q3 guidance execution

Scenario conclusions are Dilikoglu Research estimates. Company evidence, management guidance and analyst assumptions are distinguished in the analytical model.

Scenario Valuation

ScenarioProbabilityFair value / shareReturn vs price
Failure10%$12.12—
Bear25%$123.00—
Base45%$607.56—
Bull20%$1429.01—

Probability-weighted fair value: $591.16

H2 2026–FY2035 FCFF DCF; conditional warrants; exit EV/EBIT cross-check

Monte Carlo median: $484.44. Distributional cross-check, separate from the scenario valuation.

Key Base-case drivers · model 2026-10-07

These selected forecast inputs are Dilikoglu Research estimates. Units are shown explicitly; debt funding is not a lender commitment. Reported anchors and management guidance are distinguished in the full model source register.

InputBase estimateUnits
WACC10.00%
Terminal growth3.00%
Terminal ROIC30.00%
Scenario contributions and downside sensitivity

Derived from the current model above. These are scenario-weighted estimates, not calibrated probabilities of future returns.

ScenarioWeightFair valueContribution to PW
Failure10%$12.12$1.21
Bear25%$123.00$30.75
Base45%$607.56$273.40
Bull20%$1429.01$285.80

Bull contributes 48.3% of PW. Material upside-tail dependence: the weighted value should not be read as a typical outcome.

Excluding Bull and renormalizing the other weights to 100%: $381.70. Formula: sum of non-Bull weighted values ÷ (1 − Bull weight). This is a conditional diagnostic, not a replacement target.

Company-specific numerical probability calibration is not established. See the operating scenarios and falsifiers in the full analytical model.

Model

Model scope: Scenario-based independent research. Interactive controls are diagnostics; published valuation outputs reflect the published research baseline.

Open full analytical model →

Explore the interactive model here

Research

AMD · Initiation of Coverage

AMD — Initiation of Coverage

BUY · High risk · Target $610 USD · 12–18 months

Growth has a price. Execution must earn it. AMD’s Instinct and EPYC opportunity must translate into cash returns after working capital, compensation, acquisitions and customer warrants. BUY · High risk with a $610 target, implying 15.4% upside to the October 16 close of $528.75.

Revision history

This register begins with the documented baseline below. It is not a complete historical track record. Snapshot values remain fixed; the investment summary reflects the current published model.

· Report publication

Initiation of coverage

Read the dated research update →

What changed: Published BUY · High risk with a $610 target and October 16 reference close of $528.75.

Why: Present the operating, cash-flow and equity-claims analysis in a dated report.

Valuation impact: Base $607.56; probability-weighted value $591.16. Operating valuation unchanged.

Recorded Base fair value
$607.56
Recorded PW fair value
$591.16
Model date 2026-10-07 · USD per share · DR estimates

Change from recorded 2026-10-07 entry: Base +0.00; PW +0.00 USD per share. These are differences between recorded endpoints, not isolated causal contributions.

Model provenance

Model SHA-256: f2ab5f64ebbf162f8b3bb7165448e4b0e53c2a8beffc09b3825742efdd4d6f18

This fingerprint identifies the model file used to record these values.

View current model · Review source disclosures

· Baseline recorded

Dated model baseline

What changed: Recorded scenario valuation baseline.

Why: Historical starting point; the investment summary shows the current model.

Valuation impact: Dilikoglu Research estimates; no recommendation assigned.

Recorded Base fair value
$607.56
Recorded PW fair value
$591.16
Model date 2026-10-07 · USD per share · DR estimates

Change from recorded 2026-10-07 entry: Base +0.00; PW +0.00 USD per share. These are differences between recorded endpoints, not isolated causal contributions.

Model provenance

Model SHA-256: fbb928a2592be3c02e7c1af696a1e766a9bbb771b5c70cc6d8bd3c3068d5f83f

This fingerprint identifies the model file used to record these values.

View current model · Review source disclosures

· Baseline recorded

Dated model baseline

What changed: Recorded scenario valuation baseline.

Why: Historical starting point; the investment summary shows the current model.

Valuation impact: Dilikoglu Research estimates; report recommendations are separate.

Recorded Base fair value
$607.56
Recorded PW fair value
$591.16
Model date 2026-10-07 · USD per share · DR estimates
Model provenance

Model SHA-256: 3f48f179f60d274546d84ec007c88a34ddfadc17c1559af7dc7ead77b57b53d9

This fingerprint identifies the model file used to record these values.

View current model · Review source disclosures

Sources

Key Evidence

Filings and contractual documents take priority, followed by company materials and then third-party context. Forecasts are DR estimates.

Evidence review ·

Full Evidence Register

The original model ledger below records its verification status at the model date. The dated review above identifies subsequent checks and remaining limitations.

Financial anchors

Reported · USD and share amounts converted to billions. Q2 segment revenues and H1 cash flow reconcile to filings; short-term securities are separate from long-term equities.

Near-term outlook

Management guidance-commentary · Q3 midpoint and non-GAAP margin/opex anchor Base. Normalized tax guidance is not a guarantee of GAAP tax.

Long-range targets

Management guidance-commentary · Analyst Day targets cover three to five years from November 2025. They are aspirations with execution risk, not an annual guarantee; model comparison uses FY2025 to FY2030.

Operating forecasts

Dilikoglu Research estimate · Five product cohorts sum to reported segment totals. H2 mix starts with the estimated Q2 split. 2027–2030 GPU and CPU growth are explicit annual paths from annualized H2; others compound at scenario rates. For 2031–2035, growth = 2030 product growth × (1 − transition step/5) + terminal growth × transition step/5. Base GPU growth therefore slows from 50% in 2030 to 40.6%, 31.2%, 21.8%, 12.4% and 3.0%. This is a DR competitive-normalization path, not a management commitment.

Cash conversion

Dilikoglu Research estimate · Receivables, inventory, payables and residual operating assets/accruals roll forward. Loan, restricted cash and investments are excluded from operating assets; capex payable is excluded from operating liabilities and paid separately once. Commitments are allocated between procurement and service expense floors, without double counting normal costs. Uncommenced leases have estimated deployment schedules and excess capacity loss exposure.

Employee awards and customer warrants

Dilikoglu Research estimate · Existing awards enter dilution, remaining expense is added back once; future SBC remains a cost. Customer warrant eligibility uses estimated customer revenue converted to GW through expiry and a smooth price-hurdle proxy. Price and dilution are solved jointly. No duplicate warrant fair-value deduction.

Capital and terminal value

Dilikoglu Research estimate · Reported finite amortization is allocated through 2035; physical depreciation uses four/five-year remaining/new asset lives. Terminal cash flow removes expired amortization and finances growth at stated ROIC. WACC/perpetuity DCF is primary; discounted EV/EBIT is an unblended cross-check.

Simulation

Dilikoglu Research estimate · Shared demand/execution shocks drive revenue, margin, capex, collection days, warrant delivery, investments and discount rates. 20,000 seeded draws use the deterministic engine.

Liquidity and revolver

Dilikoglu Research estimate · Reported $5bn undrawn revolving facility is separate from cash and the $5.5bn commercial-paper program. Scenario-accessible revolver capacity is 50% / 75% / 100% / 100%; draws cover the operating reserve where possible, incur a 0.5% draw fee and interest, and repay from surplus cash or by estimated May 2031 maturity. Rates are 10% / 8% / 6.5% / 6%. No double counting of commercial-paper capacity or automatic renewal. Facility principal and interest affect the cash schedule; draw fees reduce FCFF. WACC captures debt financing in enterprise value, so future draws are not a second opening net-debt deduction.

Subsequent acquisitions and strategic funding

Dilikoglu Research estimate · World Labs shares = announced $8.2bn stock value / $649.42 estimated issuance price. Anthropic assumes full $5bn funding at 1.5 years; existing private-recovery scenarios apply. Liquidity uses full investment cash cost; DCF uses the investment loss allowance. Taalas unknown consideration is excluded pending disclosure and stressed at $1/$3/$5bn. These are not additive sales forecasts.

2027 operating outlook and comparable annual bridge

Management guidance-commentary / Dilikoglu Research estimate · Q2 transcript: >100% Data Center growth and >70% server CPU growth in FY2027. DR estimates use 145% GPU and 60% CPU growth versus annualized H2 2026. H1 CPU/other-DC is allocated using the estimated Q2 CPU share of reported Data Center revenue; it is not disclosed standalone server revenue. FY2027 GPU revenue is approximately $35bn, an estimate rather than guidance.

Company Filings

Company Materials

Financing / Counterparty Sources

See the company model’s evidence register for applicable disclosures.

Regulatory / Infrastructure Sources

See the company model’s evidence register for applicable disclosures.

Industry / Market Data

See the company model’s evidence register for applicable disclosures.

Research updates

Free email updates when we publish new reports or substantive research changes. No fixed sending schedule; unsubscribe at any time.

If the form does not load, use the signup link below.

Subscribe free →

Sign up through Beehiiv and confirm your email address to join. Beehiiv manages your subscription and unsubscribe options. Questions? research@dilikogluresearch.com.